2024 Diabetes Technology Meeting Agenda

DIABETES TECHNOLOGY SOCIETY

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

TUESDAY, OCTOBER 15, 2024

6:45 BREAKFAST

Workshop A, Session 1: Data Science and Artificial Intelligence

Moderator:

Shahid N. Shah, MSc

Netspective Foundation, Silver Spring, MD, USA

8:15 Rising T1DE Alliance and D-Data Dock: Transforming Care via Integration of CGM and Other Clinical Data

Mark A. Clements, MD, PhD, CPI, FAAP

Children’s Mercy Hospital, Kansas City, MO, USA

8:30 AI Technologies in Enhancing Treatment of Diabetes

Ali Cinar, PhD

Illinois Institute of Technology, Chicago, IL, USA

8:45 Digital Twins in T1D Therapy: Practical Applications and Benefits

Andrea Facchinetti, PhD

Department of Information Engineering, University of Padova, Padova, Italy

9:00 AI-enabled Dual-Hormone Pramlintide and Insulin MPC Control Algorithm and In-Silico Results

Peter G. Jacobs, PhD

Oregon Health & Science University, Portland, OR, USA

9:15 Integrating AI and Machine Learning for Prediabetes: Predictive Models and Intervention Strategies for Early Diagnosis and Management

Nestoras Mathioudakis, MD

Johns Hopkins University, Baltimore, MD, USA

9:30 Q&A

9:45 BREAK

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

TUESDAY, OCTOBER 15, 2024

Workshop A, Session 2: Real-World Evidence for Diabetes Trials

Moderator:

Sun H. Kim, MD

Department of Medicine—Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, CA, USA

10:15 Announce Breakthrough T1D/DTS Student Research Award Winners

David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE

Mills-Peninsula Medical Center, San Mateo, CA, USA

Aaron Kowalski, PhD

Breakthrough T1D, New York City, NY, USA

10:15 Spotlight-AQ Versus Usual Care for Adults with Diabetes: Cost-Effectiveness and Impact on Healthcare Professionals

Ryan Kelly, MBA

University of Portsmouth, Portsmouth, United Kingdom

10:30 Real-World Evidence Applied to Clinical Care

Julia K. Mader, MD

Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria

10:45 Harnessing University of California Health Data Warehouse to Learn Effective and Safe Treatments in Type 2 Diabetes

Rohit Vashisht, PhD

University of California, San Francisco, San Francisco, CA, USA

11:00 How Diabetes Research Hub (DRH) Modernizes and Enhances RWE Utilization

Shahid N. Shah, MS

Netspective Foundation, Silver Spring, MD, USA

11:15 Panel Discussion

11:45 LUNCH

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

TUESDAY, OCTOBER 15, 2024

Workshop B, Session 1: New Diagnostic Tests

Moderators:

George A. Brooks, PhD

Dept. of Integrative Biology, University of California, Berkeley, Berkeley, CA, USA

Koji Sode, PhD, FNAI, FAIMBE

Joint Dept. of Biomedical Engineering,

University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC, USA

13:15 Current Research Programs at Breakthrough T1D

Aaron Kowalski, PhD

Breakthrough T1D, New York City, NY, USA

13:30 Antibodies to Diagnose Diabetes

Zoe Quandt, MD

Division of Endocrinology and Metabolism, Department of Medicine,

University of California, San Francisco, San Francisco, CA, USA

13:45 Continuous Insulin Monitoring

Joseph Wang, PhD

University of California, San Diego, San Diego, CA, USA

14:00 Cardiac Blood Pressure and Exercise Monitoring

Neil Keshvani, MD

UT Southwestern Medical Center, Dallas, TX, USA

14:15 Qualitative Hypoglycemia Detection

Gerard L. Coté, PhD

Department of Biomedical Engineering, Texas A&M University, College Station, TX, USA

14:30 Q&A

14:40 BREAK

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

TUESDAY, OCTOBER 15, 2024

Workshop B, Session 2: Drugs, Insulin and Technology

Moderator:

Guillermo Arreaza-Rubín, MD

Clinical Immunology and Diabetes Technology Program, DDEM/NIDDK/NIH, Bethesda, MD, USA

15:10 Storage of Insulin

Lutz Heinemann, PhD

Science Consulting in Diabetes, Düsseldorf, Germany

15:25 Use of GLP-1 RAs Before Surgery

Sun H. Kim, MD

Department of Medicine—Endocrinology, Gerontology, and Metabolism,

Stanford University School of Medicine, Stanford, CA, USA

15:40 Solutions for Age-Related and Drug-Induced Muscle Loss: A Major Public Health Problem

Zan Fleming, MD

Kinexum, Harpers Ferry, WV, USA

15:55 Vertex Type 1 Diabetes Clinical Trials

Jean-Marc Guettier, MD

Vertex Pharmaceuticals, Boston, MA, USA

16:10 Insulin Pump Therapy in the Hospital

Robert J. Rushakoff, MD

University of California, San Francisco, San Francisco, CA, USA

16:25 Q&A

16:30 Poster Session

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

WEDNESDAY, OCTOBER 16, 2024

6:30 BREAKFAST

8:00 Welcome and Introduction

David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE

Mills-Peninsula Medical Center, San Mateo, CA, USA

8:05 Keynote Presentation—How Is the FDA OIVD Evolving to Regulate New Technologies?

Anthony Maiorana, PhD

Diabetes Branch, U.S. Food and Drug Administration, Silver Spring, MD, USA

Session 1: How Big Tech Sees Diabetes

Moderator:

Bronwyn Harris, MD

CareEvolution, Ann Arbor, Michigan, USA

8:30 Panelists

Erich Huang, MD, PhD

Verily, Durham, NC, USA

Alyssa Patel, PharmD, BCACP

Chronic Care, One Medical, San Francisco, CA, USA

Aiman Abdel-Malek, PhD

Thirdwayv Inc. and Apex Medical Ai Inc., La Jolla, CA, USA

Praveen Raja, PhD

Samsung Research America, Mountain View, CA, USA

8:35 Panel Discussion

9:40 BREAK

Session 2: New Uses of CGMs

Moderator:

Viral N. Shah, MD

Division of Endocrinology and Metabolism,

Indiana University School of Medicine, Indianapolis, IN, USA

10:10 Nutrition Monitoring for Diabetes

David Kerr, MBChB, DM, FRCP, FRCPE

Sutter Health, Santa Barbara, CA, USA

10:25 Use of CGMs by Elite Athletes

Howard Zisser, MD

University of California Santa Barbara, Santa Barbara, CA, USA

10:40 CGM for Prediabetes

Michael P. Snyder, PhD

Department of Genetics, Stanford University, Palo Alto, CA, USA

10:55 Q&A

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

WEDNESDAY, OCTOBER 16, 2024

Session 3: Who Can Sell Your Data

Moderator:

Henry Wykowksi, JD

Director, Diabetes Technology Society, Burlingame, CA, USA

11:05 An Oceania Perspective

Geoff Chase, PhD

University of Canterbury, Christchurch, New Zealand

11:20 A United States Perspective: HIPAA Considerations

Jamie E. Darch, JD

Ropes & Gray LLP, Chicago, IL, USA

11:35 A United States Perspective: FTC Considerations

Bonnie Odom, JD, MPH

Epstein Becker & Green, P.C., San Diego, CA, USA

11:50 Q&A

12:00 LUNCH

Session 4: Payers/Economics for Digital Health Interventions

Moderators:

David Kerr, MBChB, DM, FRCP, FRCPE

Sutter Health, Santa Barbara, CA, USA

Siavash Sarlati, MD

University of California, San Francisco, San Francisco, CA, USA

13:30 Panelists

Amanda Adler, MD, PhD, FRCP

Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford, United Kingdom

Jessie Juusola, PhD

Anchor Outcomes, San Francisco, CA, USA

Jordan Silberman, MD, PhD

Elevance Health, Palo Alto, CA, USA

Paul Radensky, MD, JD

McDermott Will & Emery/McDermott+, Washington, DC, USA

13:35 Panel Discussion

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

WEDNESDAY, OCTOBER 16, 2024

Session 5: Analyzing Data from a CGM

Moderator:

Robert Bem, MD, PhD, MHA

Institute for Clinical and Experimental Medicine Prague and Charles University, Prague, Czech Republic

14:30 Time in Tight Range

Peter Calhoun, PhD

Jaeb Center for Health Research, Tampa, FL, USA

14:42 Diagnostic CGM: Analytics Allowing CGM-Based Differentiation of Diabetes Stages and Treatments

Boris Kovatchev, PhD

University of Virginia, Charlottesville, VA, USA

14:54 Glycemia Risk Index

Viral N. Shah, MD

Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN, USA

15:06 Interpreting CGM Data with the Glycemia Risk Index

Ralph Oiknine, MD

Diabetes & Endocrinology Specialists Inc, Chesterfield, MO, USA

15:18 Q&A

15:30 BREAK

Session 6: How to Improve Artificial Pancreas Performance

Moderators:

Umesh Masharani, MB

University of California, San Francisco, San Francisco, CA, USA

David T. Ahn, MD

Mary & Dick Allen Diabetes Center at Hoag, Newport Beach, CA, USA

16:00 Incorporating Exercise into Closed-Loop Algorithms

Peter G. Jacobs, PhD

Oregon Health & Science University, Portland, OR, USA

16:12 Female Fertility and AID Performance: Menses and Pregnancy

Carol Levy, MD, CDCES

Division of Endocrinology, Diabetes, and Metabolism,

Icahn School of Medicine at Mount Sinai, New York City, NY, USA

16:24 Bihormonal Closed-Loop Control

Steven J. Russell, MD, PhD

Massachusetts General Hospital Diabetes Research Center, Boston, MA, USA

16:36 The Use of GLP-1RAs with AIDs

Viral N. Shah, MD

Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN, USA

16:48 Q&A

17:00 Poster Session

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

THURSDAY, OCTOBER 17, 2024

6:30 BREAKFAST

Session 7: How Tech Can Improve Adherence to Diabetes Rx

Moderator:

Ny’Nika T. McFadden, PhD

Dept. of Public Health, Texas State University, San Marcos, TX, USA

8:00 Using Behavioral Science and Design Thinking to Develop More Engaging Digital Diabetes Innovations

Paula Voorheis, PhD

Science of Care Institute, Sinai Health System, Toronto, ON, Canada

8:15 Three Key Technologies that Improve Adherence Among Diabetes Patients Within the Los Angeles General Medical Center, the Largest Medical Center in the Los Angeles County Health Care System

Wei-An (Andy) Lee, DO

Los Angeles General Medical Center, Los Angeles, CA, USA

8:30 How Technology Enhances Patient Engagement

William Polonsky, PhD

Behavioral Diabetes Institute & University of California, San Diego, San Diego, CA, USA

8:48 Q&A

Session 8: Accuracy of Diabetes Devices

Moderators:

Carsten Benesch, PhD

Profil Institut for Metabolic Research GmbH, Neuss, Germany

George Cembrowski, MD, PhD

University of Alberta, Edmonton, Alberta, Canada

9:00 The New DTS Error Grid and Trend Accuracy Matrix

Michael Kohn, MD, MPP

University of California, San Francisco, San Francisco, CA, USA

9:15 Reliability and Comparability of CGM Performance Endpoints

Guido Freckmann, MD

Institute for Diabetes Technology at Ulm University, Ulm, Germany

9:30 Limitations of Using the MARD for Accuracy

Jan Krouwer, PhD

Krouwer Consulting, Sherborn, MA, USA

9:45 Q&A

9:55 BREAK

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

THURSDAY, OCTOBER 17, 2024

Session 9: Innovation Challenge

Moderators:

Zan Fleming, MD

Kinexum, Harpers Ferry, West Virginia, USA

Aiman Abdel-Malek, PhD

Thirdwayv Inc. and Apex Medical Ai Inc., La Jolla, CA, USA

10:25 About DCB and the Open DCB Innovation Challenge

Ema Grabenweger, MA

Diabetes Center Berne, Berne, Switzerland

10:35 Unleashing the Power of Next-Gen Monitoring for Diabetes

Muhammad Mujeeb-U-Rahman, PhD

Integrated Medical Sensors Inc., Irvine, CA, USA

10:42 Device to Reduce Incidence of Lipohypertrophy in Long-Term Insulin Users [Video]

Sufyan Hussain, MB Bchir

Innodose, London, United Kingdom

10:49 A Digital Ecosystem to Educate Children with Type 1 Diabetes Through Safe Experimentation with Gamified Diabetes Simulators

Jorge Bondia, PhD

AMIC Health, Valencia, Spain

10:56 Calculating Insulin Resistance Based on Level of Physical Activity

Christine Brännvall, BS

Beep Insights, Kiruna, Sweden

11:03 Evidence-Based Neurocognitive Digital Therapeutics to Restore Healthy Consumption Behaviors Without Awareness

Frédérik Plourde, MSc

Neuria Digital Therapeutics, Fribourg, Switzerland

11:10 Innovative DNA Testing: A New Horizon in Type 1 Diabetes Diagnosis

Yuta Matsuda, MS

Genomelink Inc., Berkeley, CA, USA

11:17 Q&A

11:28 Concluding Remarks

Ema Grabenweger, MA

Diabetes Center Berne, Berne, Switzerland

11:30 LUNCH

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

THURSDAY, OCTOBER 17, 2024

Session 10: Physiology of Inserted and Implanted Devices (_{non-accredited)}

Moderator:

Lutz Heinemann, PhD

Science Consulting in Diabetes, Düsseldorf, Germany

1:00 The Science of Extended Wear Infusion Sets

Rayhan Lal, MD

Stanford University, Palo Alto, CA, USA

13:12 Update on Optical Glucose Measurement

Mark A. Arnold, PhD

The University of Iowa, Iowa City, IA, USA

13:24 The DERMIS Study: What Does Insulin Pump Therapy do to the Skin, and Where Do We Go from Here?

Irl B. Hirsch, MD

University of Washington, Seattle, WA, USA

13:36 The Technology Behind Continuous Blood Glucose Monitoring

Mark Tapsak, PhD

Glucotrack, Rutherford, NJ, USA

13:48 Q&A

Session 11: New Developments in CGM Products (_{non-accredited)}

Moderator:

Timothy S. Bailey, MD

Advanced Metabolic Care and Research Institute, Escondido, CA, USA

14:00 Update from Abbott

Marc Taub, PhD

Abbott Diabetes Care, Chicago, IL, USA

14:10 Update from Dexcom

Jessica Castle, MD

Dexcom, Inc, San Diego, CA, USA

14:20 Update from Medtronic

Lou Lintereur, MS

Medtronic Diabetes, Los Angeles, CA, USA

14:30 Update from Roche

Timor Glatzer, PhD

Roche Diabetes Care, Inc, Mannheim, Germany

14:40 Update from Senseonics

Hari Sree, PhD

Senseonics Inc., Germantown, MD, USA

14:50 Q&A

15:00 BREAK

DTM 2O24

24TH ANNUAL DIABETES TECHNOLOGY MEETING AGENDA

THURSDAY, OCTOBER 17, 2024

Session 12: Hot Topics

Moderators:

Bijan Najafi, PhD

Center for Advanced Surgical & Interventional Technology, University of California, Los Angeles, Los Angeles, CA, USA

Kelly Close, MBA

Close Concerns, San Francisco, CA, USA

15:30 ChatGPT Applied to Diabetes

Sultan A. Meo, MBBS, PhD, MMed Ed, FRCP

College of Medicine, King Saud University, Riyadh, Saudi Arabia

15:45 Green Diabetes Project

Lutz Heinemann, PhD

Science Consulting in Diabetes, Düsseldorf, Germany

16:00 Use of CGMs in People without Diabetes

Tracey McLaughlin, MD, MPH

Stanford School of Medicine

16:15 Continuous Glucose Monitoring (CGM)-Based Titration of Once-Weekly Insulin Icodec in InsulinNaïve Individuals with Type 2 Diabetes (ONWARDS 9)

Richard Bergenstal, MD

International Diabetes Center, Minneapolis, MN, USA

Session 13: Live Demonstration

Moderators:

Gerald Sydorak, MD, FACS

Seton Wound Care, Daly City, CA, USA

Dorian Liepmann, PhD

Dept. of Bioengineering, University of California, Berkeley, Berkeley, CA, USA

16:35 An Implantable Continuous Glucose Monitor

Paul Goode, PhD

Glucotrack, Rutherford, NJ

16:50 Concluding Remarks

David C. Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE

Mills-Peninsula Medical Center, San Mateo, CA, USA

17:00 Adjourn